| P50 | author | Magnus J Hansson | Q43208349 |
| | Johannes K H Ehinger | Q85484752 |
| P2093 | author name string | Eskil Elmér | |
| | Saori Morota | |
| | Gesine Paul | |
| P2860 | cites work | Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease | Q24294639 |
| | Huntington's disease | Q28284355 |
| | Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients. | Q30304195 |
| | N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking | Q30486372 |
| | Beyond the brain: widespread pathology in Huntington's disease | Q33483188 |
| | Patients with sepsis exhibit increased mitochondrial respiratory capacity in peripheral blood immune cells | Q33752546 |
| | Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. | Q33911613 |
| | Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin | Q34483577 |
| | Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity | Q34634421 |
| | Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease | Q34838143 |
| | Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients | Q35609642 |
| | Normal platelet mitochondrial complex I activity in Huntington's disease | Q36274461 |
| | Huntington's disease: the current state of research with peripheral tissues. | Q37491501 |
| | Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. | Q37495197 |
| | An insight into ultrastructural and morphological alterations of platelets in neurodegenerative diseases | Q37853182 |
| | Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes | Q38028375 |
| | Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients | Q40207281 |
| | Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences | Q40231756 |
| | Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation | Q40351019 |
| | Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release | Q40551652 |
| | Aberrant A2A receptor function in peripheral blood cells in Huntington's disease | Q40564008 |
| | Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. | Q40721588 |
| | Huntingtin is required for normal hematopoiesis | Q40902755 |
| | Regional mitochondrial respiratory activity in Huntington's disease brain | Q41360902 |
| | Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. | Q42438521 |
| | Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease | Q45259959 |
| | Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. | Q45290069 |
| | Huntington disease: Clinical care and evaluation | Q45290085 |
| | Mitochondrial defect in Huntington's disease caudate nucleus | Q45291734 |
| | Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease | Q45292252 |
| | Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease | Q45294442 |
| | Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases | Q45296514 |
| | Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts | Q45296864 |
| | Biochemical abnormalities and excitotoxicity in Huntington's disease brain. | Q45297145 |
| | Genotype-, aging-dependent abnormal caspase activity in Huntington disease blood cells. | Q45302615 |
| | Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes | Q48910244 |
| | Mitochondrial respiration in human viable platelets--methodology and influence of gender, age and storage. | Q52631832 |
| | Unified Huntington's disease rating scale: Reliability and consistency | Q57422462 |
| | Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group | Q67973678 |
| | Abnormalities of the electron transport chain in idiopathic Parkinson's disease | Q69361952 |
| | Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients | Q83748135 |
| | Mitochondrial diseases | Q83827338 |
| | Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization | Q95810356 |
| P433 | issue | 5 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 472-482 | |
| P577 | publication date | 2016-02-11 | |
| P1433 | published in | Movement disorders clinical practice | Q27725493 |
| P1476 | title | Mitochondrial Respiratory Function in Peripheral Blood Cells from Huntington's Disease Patients | |
| P478 | volume | 3 | |